Baird Says Time is Right to Own NewLink Genetics (NLNK)

Go back to Baird Says Time is Right to Own NewLink Genetics (NLNK)

Newlink Genetics (NLNK) Posts Q3 Loss of 28c

October 31, 2012 7:09 AM EDT

Newlink Genetics (NASDAQ: NLNK) reported Q3 EPS of ($0.28), $0.04 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $327 thousand versus the consensus estimate of $420 thousand.

For earnings history and earnings-related data on Newlink Genetics (NLNK) click here.... More